EIR Wyeth BioPharma Division of Wyeth Pharmaceuticals Feb 2014

Debra Emerson FDA, Arie Menachem FDA$595.00 - Available Now

FDA investigators audited the Wyeth BioPharma Division of Wyeth Pharmaceuticals - Andover, MA, United States facility and issued inspectional observations (via FDA 483) on 28 Feb 2014.

Add To Cart

Product details

  • Category:
  • Inspection end: 28 Feb 2014
  • Location: Andover, United States